Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma

Cancer

Volumn 91, Issue 12, 2001, Pages 2230-2237

  Reddick, Wilburn E ^a   Wang, Sihong ^b   Xiong, Xiaoping ^b   Glass, John O ^a   Wu, Shengjie ^a   Kaste, Sue C ^c   Pratt, Charles B ^a   Meyer, William H ^c   Fletcher, Barry D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b University of Memphis   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Dynamic contrast magnetic resonance imaging; Osteosarcoma; Tumor microcirculation; Tumor response

Indexed keywords

CARBOPLATIN; CONTRAST MEDIUM; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OSTEOSARCOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 0035876338     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010615)91:12<2230::AID-CNCR1253>3.0.CO;2-T     Document Type: Article

References (39)

1. Delivery of molecular medicine to solid tumors
2. Barriers to drug delivery in solid tumors
3. 1995 Whitaker lecture: Delivery of molecules, particles, and cells to solid tumors
4. Time-dependent behavior of interstitial fluid pressure in solid tumors: Implications for drug delivery
5. Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy
6. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma
7. Osteosarcoma chemotherapy effect: A prognostic factor
8. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
9. Pediatric osteosarcoma: Therapeutic strategies, results, and prognostic factors derived from a 10-year experience
10. Chemotherapy for non-metastatic ostegenic sarcoma: The Memorial Sloan-Kettering experience
11. Response of osteosarcoma and ewing sarcoma to preoperative chemotherapy: Assessment with dynamic and static MR imaging and skeletal scintigraphy
12. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy
13. Pediatric musculoskeletal tumors: Use of dynamic contrast-enhanced MR imaging to monitor response to chemotherapy
14. Assessment of osteosarcoma response to pre-operative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping
15. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: Preliminary results
16. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy
17. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: Basic principles and clinical applications
18. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
19. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging
20. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors
21. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging
22. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography
23. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model
24. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution
25. Carboplatin/Ifosfamide window therapy for osteosarcoma: Results of the St. Jude Children's Research Hospital OS-91 trial
26. Discrete signal processing of dynamic contrast-enhanced MR imaging: Statistical validation and preliminary clinical application
27. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers
28. Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation
29. Proton relaxation in dilute solutions of cobalt (II) and nickel(II) ions in methanol and the rate of methanol exchange of the solvation sphere
30. An analysis of fast imaging sequences with steady-state magnetization refocusing
31. Contrast in rapid MR imaging: T1- and T2-weighted imaging
32. Regression models and life-tables
33. Partial likelihood
34. Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery
35. Survival, prognosis, and therapeutic response in osteogenic sarcoma
36. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma
37. MR imaging of tumor microcirculation: Promise for the new millennium
38. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI
39. Tumor size and prognosis in aggressively treated osteosarcoma